dobutamine has been researched along with xamoterol in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 5 (55.56) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Erhardt, PW | 1 |
Isogaya, M; Kikkawa, H; Kurose, H; Nagao, T; Sugimoto, Y; Tanaka, R; Tanimura, R | 1 |
Topliss, JG; Yoshida, F | 1 |
Bals, S; Brodde, OE; Deighton, NM; Motomura, S; Zerkowski, HR | 1 |
Kjaerulf-Jensen, H; Korsgaard, N; Lindeberg, H; Vigholt-Sørensen, E | 1 |
Fournier, P; Fraysse, JB; Grosgogeat, Y; Komajda, M; Landault, C; Lechat, P; Richaud, M | 1 |
Burkard, WP; Eigenmann, R; Goodman, M; Holck, M; Märki, HP; Melmon, KL; Osterrieder, W | 1 |
Fischmeister, R; Jurevicius, J; Skeberdis, VA | 1 |
Bross, T; Geiger, KK; Hoetzel, A; Humar, M; Loop, T; Pahl, HL; Pannen, BHJ; Schmidt, R | 1 |
2 review(s) available for dobutamine and xamoterol
Article | Year |
---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol | 1990 |
1 trial(s) available for dobutamine and xamoterol
Article | Year |
---|---|
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol | 1990 |
7 other study(ies) available for dobutamine and xamoterol
Article | Year |
---|---|
Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alanine; Albuterol; Amino Acid Substitution; Animals; Binding Sites; Computer Simulation; COS Cells; Ethanolamines; Formoterol Fumarate; Humans; Models, Molecular; Norepinephrine; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Recombinant Fusion Proteins; Xamoterol | 1999 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium.
Topics: Adrenergic beta-Agonists; Adult; Aged; Calcium; Deoxyepinephrine; Dobutamine; Dopamine; Ethanolamines; Female; Heart Atria; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Propanolamines; Stimulation, Chemical; Xamoterol | 1992 |
Myocardial ultrastructure in the isolated rabbit heart exposed to dopamine, dobutamine, isoprenaline, G-strofanthin, xamoterol and hypoxia.
Topics: Adrenergic Agonists; Animals; Cell Hypoxia; Dobutamine; Dopamine; Female; Isoproterenol; Male; Mitochondria, Heart; Myocardial Contraction; Myocardium; Oxygen Consumption; Rabbits; Stimulation, Chemical; Strophanthins; Xamoterol | 1992 |
In vitro pharmacological properties of a series of isoprenaline derivatives.
Topics: Animals; Aorta, Thoracic; Binding, Competitive; Catecholamines; Dihydroalprenolol; Dobutamine; Dogs; Electrophysiology; Female; Guinea Pigs; In Vitro Techniques; Isomerism; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Myocardial Contraction; Papillary Muscles; Potassium; Propanolamines; Rabbits; Receptors, Adrenergic, beta; Xamoterol | 1989 |
Pharmacological characterization of the receptors involved in the beta-adrenoceptor-mediated stimulation of the L-type Ca2+ current in frog ventricular myocytes.
Topics: Albuterol; Animals; Calcium Channels; Calcium Channels, L-Type; Dobutamine; Dose-Response Relationship, Drug; In Vitro Techniques; Isoproterenol; Myocardium; Propanolamines; Rana esculenta; Receptors, Adrenergic, beta; Xamoterol | 1997 |
Dobutamine inhibits phorbol-myristate-acetate-induced activation of nuclear factor-kappaB in human T lymphocytes in vitro.
Topics: Adrenergic Agents; Adrenergic beta-Agonists; Anti-Inflammatory Agents; CD3 Complex; Cell Nucleus; Clenbuterol; DNA; Dobutamine; Electrophoretic Mobility Shift Assay; Humans; Jurkat Cells; NF-kappa B; Receptors, Adrenergic, alpha; T-Lymphocytes; Tetradecanoylphorbol Acetate; Xamoterol | 2004 |